T he U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone to treat men with prostate cancer. Jevtana is the first treatment for advanced, hormone-refractory, prostate cancer that has worsened during or after ...
"The success of TULSA represents a revolution in whole-gland treatment forprostate cancer," said lead author Steven S. Raman, M.D., FASR, FSIR, professor of radiology, urology and surgery at the David Geffen School of Medicine at UCLA. "Prostate cancer is the most common form of cancer ...
For the first time, researchers have discovered that prostate cancer can be killed by targeting a single enzyme, called PI5P4Kα. The findings, published recently inScience Advances, could help address the growing threat of treatment resistance in prostate cancer and could also lead to improved t...
New Treatment Option In The Fight Against Prostate Cancer - Implant Gives Men Flexibility In Treatment Choices
In 1982, Schally et al introduced a radically different hormonal therapy for prostate cancer, based on the use of highly potent synthetic agonistic analogues of luteinising hormone-releasing hormone (LHRH) for the treatment of advanced prostate cancer [1], [2], [3], [4], [5]. The isolatio...
CHICAGO, June 4 (Xinhua) -- A combination of two existing prostate cancer therapies could extend lives of men with advanced, high-risk prostate cancer, a study showed. The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed...
Treating those suffering from prostate cancer with radiotherapy on top of regular treatment could extend the life of men with advanced forms of the disease, research has found. One of the largest ever clinical trials into prostate cancer found an 11% increase in the survival rate of some patient...
May 31st 2022 Podcast Judd W. Moul, MD, spoke with CancerNetwork® about the latest research from the journal ONCOLOGY® on the treatment of a patients with evidence of prostate cancer despite multiple negative prognostic tests. SBRT Emerges as Viable Treatment for Localized Prostate Cancer Tim...
In recent years the pace of research in prostate cancer has increased dramatically. Creative ideas in combination with new and emerging technologies have led to an explosion of discovery. These types of advances in prostate cancer research presage an era of new treatment strategies based on an unde...
eradicating that tumourcell population, there is a risk of subsequent uncontrolled growth of the tumour. The cancer stem cells are often unresponsive to both hormonal treatment and to chemotherapy, so it is essential to develop a direct treatment towards all types of cancer cells", says Anders B...